INTRODUCTION
The elimination of racial and ethnic disparities in health is an overarching goal of U.S. public health policy. Although the magnitude of the disparities is evidenced in a plethora of diseases across racial and ethnic groups, the extent of the problem is no more clearly illustrated than in cancer among African Americans. Overall, they are [...]
These data suggest that within each age-gender subgroup, whether or not an individual has health insurance and a source of usual care is the most important modifiable factors driving use of needed health services within the African-American population. Poverty is also a significant and modifiable factor. Combining the three factors of health insurance, adequate income, [...]
There was valid data for 3,462 African-American respondents to the survey, representing a U.S. African-American population of 36,538,639 civilian, noninstitutionalized persons. Respondents had a median age of 30.0 years. Differences in self-reported health status and mental health status were not striking, but showed a predictable decline in health status with age, and worse health status [...]
Source
Data for the U.S. civilian, noninstitutionalized population were taken from the 1999 Medical Expenditure Panel Survey (MEPS) sponsored by the Agency for Healthcare Research and Quality (AHRQ). MEPS is a nationally representative survey of a sample of households drawn from previous National Health Interview Survey (NHIS) participants. Data in 1999 were collected for 23,565 persons [...]
INTRODUCTION
Racial and ethnic disparities in healthcare have been documented in numerous studies, which have been summarized in national reports, such as the Institute of Medicine’s Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care* and various Kaiser Family Foundation reports on Race, Ethnicity, and Medical Care. Some of the most rigorously documented studies have [...]
This pilot study demonstrated the feasibility, acceptability, and potential efficacy of a culturally competent intervention designed to target multiple breast cancer risk factors.
Although a number of breast cancer (Generic Nolvadex is used for treating breast cancer) risk-reduction programs have been shown to be feasible, acceptable, and efficacious with African-American women, these programs targeted either early detection [...]
Data were entered and verified for 30 women who completed the and postintervention and one-year follow-up interviews. Nine women did not complete the postintervention interview, and 14 did not return for the one-year follow-up.
